Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-κB signaling
Open Access
- 2 August 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 165, 115275
Abstract
No abstract availableKeywords
Funding Information
- Science Fund for Distinguished Young Scholars of Fujian Province (2022J06027)
- Fujian University of Traditional Chinese Medicine
This publication has 32 references indexed in Scilit:
- The NF-κB Subunit c-Rel Stimulates Cardiac Hypertrophy and FibrosisThe American Journal of Pathology, 2012
- Angiotensin II and norepinephrine activate specific calcineurin-dependent NFAT transcription factor isoforms in cardiomyocytesJournal of Applied Physiology, 2011
- Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failureCardiovascular Research, 2010
- Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophyCardiovascular Research, 2009
- NF- B activation is required for adaptive cardiac hypertrophyCardiovascular Research, 2009
- Prevention of Cardiac Hypertrophy and Heart Failure by Silencing of NF-κBJournal of Molecular Biology, 2008
- Involvement of transient receptor potential proteins in cardiac hypertrophyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-κB activity and AT1 receptor expressionBiochemical and Biophysical Research Communications, 2004
- Cardiac Hypertrophy: The Good, the Bad, and the UglyAnnual Review of Physiology, 2003
- Activation of nuclear factor-κB is necessary for myotrophin-induced cardiac hypertrophyJournal of Cell Biology, 2002